ASTEC quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Astec Lifesciences Ltd reported sales of ₹72 Cr, operating profit of ₹-20 Cr (OPM -27%) and net profit of ₹-37 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
ASTEC quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
94
120
91
74
125
159
84
72
Expenses
100
114
102
80
121
149
84
92
Operating Profit
-6
6
-11
-7
4
9
-1
-20
OPM
-6%
4.6%
-12%
-9%
3.2%
6%
-0.8%
-27%
Other Income
2
1
1
1
-1
3
1
1
Interest
10
10
11
8
7
8
8
7
Depreciation
11
12
11
10
11
12
11
11
Profit before tax
-25
-16
-33
-24
-16
-8
-19
-37
Tax
61%
3%
0%
0%
0%
-2%
0%
0%
Net Profit
-40
-16
-33
-24
-16
-8
-19
-37
EPS in Rs
-18.03
-7.18
-14.75
-10.96
-7.05
-3.48
-8.4
-16.79
ASTEC profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
677
628
458
381
448
439
Expenses
522
551
464
448
453
446
Operating Profit
154
77
-6
-66
-4
-7
OPM
23%
12%
-1.3%
-17%
-1%
-1.7%
Other Income
10
13
6
6
3
3
Interest
9
21
25
37
35
30
Depreciation
34
34
36
44
45
45
Profit before tax
121
35
-62
-141
-81
-80
Tax
26%
27%
-24%
-4%
0%
-
Net Profit
90
26
-47
-135
-81
-80
EPS in Rs
40.12
11.41
-20.95
-60.16
-36.32
-35.72
Dividend Payout
3%
12%
0%
0%
0%
-
ASTEC balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
20
20
22
22
22
Reserves
350
215
392
368
312
Borrowings
494
555
367
449
330
Other Liabilities
112
92
102
102
129
Total Liabilities
975
881
883
942
794
Fixed Assets
386
499
500
459
457
CWIP
165
21
0
20
1
Investments
0
0
0
0
0
Other Assets
424
361
383
463
337
Total Assets
975
881
883
942
794
ASTEC cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
24
75
10
-8
-81
Cash from Investing Activity
-104
-113
-135
-15
-4
Cash from Financing Activity
80
38
125
24
94
Net Cash Flow
0
0
0
0
9
Free Cash Flow
-80
-42
-125
-24
-86
CFO/OP
34%
104%
-211%
20%
1,796%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit